Related Experiment Video
Updated: Jan 14, 2026

In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model
Published on: November 17, 2018
Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases
Monika Jakubowska1, Vera Marisa Costa2, Wojciech Krzeptowski3
1Malopolska Centre of Biotechnology, Jagiellonian University in Krakow, Krakow, Poland.
Abstract:
The balanced activity of the cytoprotective transcription factor NRF2 is central for maintaining redox, metabolic-energetics, and proteome homeostasis, as well as for regulating inflammatory responses, among other functions. Activated NRF2 regulates the expression of hundreds of genes containing antioxidant response elements (AREs) or electrophile response elements (EpRE) in their regulatory regions, often promoting cytoprotection under stress conditions and contributing to defence against various pathologies and non-communicable diseases (NCDs). The products of increased NRF2 activity, detected systemically, may originate from either the white blood cells, the cells of the vasculature or tissue-derived products that could be secreted into biological fluids. Therefore, assessing basal and inducible NRF2 activity in blood or other biofluids is crucial for inferring NRF2 responses in local and often inaccessible tissues. In previous work, we identified a panel of six biomarkers - Glutamate-cysteine ligase catalytic subunit (GCLC), Glutamate-cysteine ligase modifier subunit (GCLM), Haem oxygenase 1 (HMOX1), NAD(P)H quinone dehydrogenase 1 (NQO1), Sulfiredoxin 1 (SRXN1), and Thioredoxin reductase 1 (TXNRD1) - as indicators of NRF2 activity. In the current study, we assess their utility in a clinical setting to measure NRF2 activation in a disease context. Here we discuss findings on how NRF2 activity in accessible human samples can reveal its involvement in various NCDs and its connection to clinical aspects such as diagnosis, disease progression and response to therapy.
Insights
Assessing Nuclear factor erythroid 2-related factor 2 (NRF2) activity in blood samples offers insights into its role in various diseases. This approach aids in understanding NRF2
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Biology
Background:
- Nuclear factor erythroid 2-related factor 2 (NRF2) is a key transcription factor regulating cellular defense mechanisms.
- Balanced NRF2 activity is crucial for maintaining homeostasis and combating pathologies, including non-communicable diseases (NCDs).
- Systemic detection of NRF2 activity products may reflect local tissue responses, necessitating accessible measurement methods.
Purpose of the Study:
- To evaluate the clinical utility of a panel of six NRF2 activity biomarkers in accessible human samples.
- To assess the connection between NRF2 activation and the diagnosis, progression, and therapeutic response in NCDs.
Main Methods:
- Utilized a previously identified panel of six biomarkers: Glutamate-cysteine ligase catalytic subunit (GCLC), Glutamate-cysteine ligase modifier subunit (GCLM), Haem oxygenase 1 (HMOX1), NAD(P)H quinone dehydrogenase 1 (NQO1), Sulfiredoxin 1 (SRXN1), and Thioredoxin reductase 1 (TXNRD1).
- Assessed the biomarkers' utility in a clinical setting to measure NRF2 activation in disease contexts.
- Discussed findings on how NRF2 activity in blood and biofluids can reveal its involvement in NCDs.
Main Results:
- The study validated the utility of the six biomarkers for measuring NRF2 activity in clinical samples.
- NRF2 activity in accessible samples correlates with various NCDs, offering insights into disease mechanisms.
- Findings suggest NRF2 activity is linked to clinical aspects like diagnosis, disease progression, and treatment response.
Conclusions:
- Measuring NRF2 activity in accessible human samples provides a valuable tool for clinical assessment of NCDs.
- This approach can help infer NRF2 responses in local tissues and inform clinical management.
- The identified biomarkers serve as indicators of NRF2 activation relevant to disease states.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Redox Reactions
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Regulation of the Unfolded Protein Response
Peroxisomes
